Spots Global Cancer Trial Database for A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
Official Title: A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
Study ID: NCT01969877
Conditions
Study Description
Brief Summary: The primary endpoint in this study is to investigate if there is a difference in overall survival in patients with locally advanced head and neck cancer, randomized to either radiotherapy and cetuximab or radiotherapy and cisplatin. A second randomization is performed in patients with T3-T4 tumors; allocated radiotherapy either 68.0 Gy or 73.1 Gy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Gävle Hospital, Gävle, , Sweden
Sahlgrenska University Hospital, Göteborg, , Sweden
County Hospital Ryhov, Jönköping, , Sweden
Central Hospital, Karlstad, , Sweden
University Hospital Linköping, Linköping, , Sweden
Karolinska Universityhospital, Stockholm, , Sweden
Norrland University Hospital, Umeå, , Sweden
Västmanlands Hospital Västerås, Västerås, , Sweden
University Hospital Örebro, Örebro, , Sweden
Contact Details
Name: Maria Gebre-Medhin, MD, PhD
Affiliation: Lund University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
